Treatment duration of adjuvant immune checkpoint inhibitors in hepatocellular carcinoma patients at high risk of recurrence after resection: A prospective, multicentric cohort study
Authors
Jia‐Yong Su,
Shaoping LiuXiaoling Xu,
J. Ou,
P Ye,
Baowei Zhao,
Jia-Song Chen,
Qingli Luo,
Jinrong Liu,
Fang Tang,
Jianrong Li,
Da-Long Yang,
Zhu‐Jian Deng,
Lixin Pan,
Yaojie Li,
Le Li,
Zhen-Ming Qin,
Xiumei Liang,
Yi-Li Ma,
Yong‐Min Liang,
Jian‐Hong Zhong,
Liang Ma +20 authors
,
Yukui Zhang
Tip
Tip